Using a logrank test, we found that NSCLC patients with high KDM1A and low TIMP3 expressions are more significantly associated with poor prognosis (P = 0.000021), than other groups of patients with high KDM1A and high TIMP3 (P = 0.020578), or low KDM1A and low TIMP3 expressions (P = 0.000403), when compared to those with low KDM1A and high TIMP3 expressions (Figure 8C). This evidence concerns the gene KDM1A and non-small cell lung carcinoma.